TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer

Journal: Journal of Clinical Investigation

Published: 2018-05-07

DOI: 10.1172/jci96148

Affiliations: 17

Authors: 24

Go to article
Institutions FC
Department of Neurology and Neurotherapeutics, UT Southwestern Medical Center, United States of America (USA) 0.10
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, United States of America (USA) 0.10
UCSF Department of Medicine (DOM), United States of America (USA) 0.08
Quantitative Biomedical Research Center (QBRC), UT Southwestern Medical Center, United States of America (USA) 0.08
Department of Radiology, UT Southwestern Medical Center, United States of America (USA) 0.08
Department of Radiation Oncology, UT Southwestern Medical Center, United States of America (USA) 0.08
Department of Pharmacology, UT Southwestern Medical Center, United States of America (USA) 0.08
Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, United States of America (USA) 0.08
Division of Hematology and Oncology, UT Southwestern Medical Center, United States of America (USA) 0.06
Department of Pathology, UT Southwestern Medical Center, United States of America (USA) 0.04
Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, United States of America (USA) 0.04
Baylor Scott and White Research Institute (BSWRI), United States of America (USA) 0.04
Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.04
VA North Texas Health Care System, United States of America (USA) 0.03
Department of Clinical Sciences, UT Southwestern Medical Center, United States of America (USA) 0.02
Department of Cancer Biology, WFU, United States of America (USA) 0.02
Department of Biomedical Engineering (BME), WFU, United States of America (USA) 0.02

Return